Aug 3, 2026 07:09AM
Jun 16, 2026 08:01AM
Jun 15, 2026 06:05AM
Apr 29, 2026 09:08AM
Apr 27, 2026 08:47AM
Feb 23, 2026 08:31AM
Dec 12, 2025 04:17PM Adial Pharmaceuticals (ADIL) files for 13.82M share offering by selling stockholders
Nov 26, 2025 08:01AM
Nov 14, 2025 04:25PM
Oct 9, 2025 08:32AM
Sep 30, 2025 07:38AM
Sep 3, 2025 08:30AM
Aug 20, 2025 08:31AM
Aug 6, 2025 08:02AM Adial Pharmaceuticals completes FDA meeting for AD04 phase 3 trial
Jul 9, 2025 08:32AM
Jun 25, 2025 08:35AM
Jun 17, 2025 08:02AM
Jun 11, 2025 08:01AM
May 30, 2025 04:14PM
May 8, 2025 08:30AM
May 2, 2025 11:49AM Adial Pharmaceuticals (ADIL) Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds
May 1, 2025 08:32AM
Mar 4, 2025 09:59AM
Feb 25, 2025 09:01AM
Feb 19, 2025 09:02AM
Feb 12, 2025 09:01AM
Jan 29, 2025 09:02AM
Dec 3, 2024 08:31AM Adial Pharmaceuticals (ADIL) Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations
Nov 14, 2024 08:40AM
Nov 14, 2024 06:38AM
Nov 5, 2024 08:30AM
Oct 17, 2024 09:03AM
Sep 19, 2024 08:31AM
Aug 13, 2024 09:03AM
Jul 31, 2024 08:32AM Adial Pharmaceuticals (ADIL) Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044

443,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All